Document is current

Article History

Received: 31 August 2020

Accepted: 2 November 2020

First Online: 11 November 2020

Ethics approval and consent to participate

: This study was approved by the Institutional Review Board at the Hospital Clinic of Barcelona (HCB/2016/0905) and it was conducted in accordance with the Tenets set forth in the Declaration of Helsinki. No written informed consent was required as data was retrospectively collected from routine clinical care, as approved by the reference Institutional Review Board.

: Not applicable.

: JZV has been in advisory boards and is a consultant, lecturer, grant recipient and has received travel grants from Alcon, Alimera Sciences, Allergan, Bausch and Lomb, Bayer, Brill Pharma, DORC, Novartis, Roche, Topcon and Zeiss; BRN, none; CBM, none; DVV, none; ASP has given lectures for Allergan and Bayer and is a member of the Allergan International Retina Panel; MFR has given lectures for Allergan; SC, none; LD, none; AB has given lectures for Allergan, Bayer, and Novartis; JGA has been in advisory boards and has received grants from Alcon, Allergan, Bayer, Novartis; AA has been in advisory boards and is a consultant for Abbvie, Alcon, Alimera Sciences, Allergan, Bayer and Novartis, and has given lectures for Topcon and Zeiss.